Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€3.16
18.05.22
€15.00
18.05.23
292.41%
29.07.22

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
buy
American Public Ed.

Start price
Target price
Perf. (%)
€13.40
18.05.22
€18.00
18.05.23
-57.09%
19.05.23

Could be worthwhile Investment >10% per year
Good culture
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
10.77%
28.05.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
SAP SE

Start price
Target price
Perf. (%)
€93.60
18.05.22
-
18.05.23
-5.24%
14.06.22

Could be very worthwhile Investment >20% year
High dividend yield expected
EBIT decline > 20% expected
buy
Paypal Holdings Inc. CDR

Start price
Target price
Perf. (%)
€4.70
18.05.22
-
18.05.23
6.38%
27.07.22

buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€44.26
18.05.22
-
18.05.23
5.47%
28.05.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
Could be very worthwhile Investment >20% year
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€11.05
18.05.22
-
18.05.23
-0.45%
28.05.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.16
18.05.22
-
18.05.23
2.59%
28.05.22

Could be very worthwhile Investment >20% year
Undervalued
buy
SGL Carbon SE

Start price
Target price
Perf. (%)
€5.63
18.05.22
-
18.05.23
3.20%
28.05.22

Higher EBIT margin than peer group
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Mister Spex SE

Start price
Target price
Perf. (%)
€5.69
18.05.22
-
18.05.23
-4.22%
28.05.22

Future proof or reliable business model
Top 10 in its market
EBIT decline/stagnation expected
Probably not worthwhile Investment
buy
Valmont Industries Inc.

Start price
Target price
Perf. (%)
€238.00
18.05.22
-
18.05.23
10.92%
18.05.23

buy
Genuine Parts Corp

Start price
Target price
Perf. (%)
€124.86
18.05.22
-
18.05.23
22.50%
18.05.23

buy
Alfen

Start price
Target price
Perf. (%)
€94.00
18.05.22
-
18.05.23
-28.70%
18.05.23

buy
Cognizant Technology Solutions Corp.

Start price
Target price
Perf. (%)
€69.78
18.05.22
-
18.05.23
-15.63%
18.05.23

buy
Xylem Inc.

Start price
Target price
Perf. (%)
€79.69
17.05.22
€117.00
17.05.23
19.21%
17.05.23

buy
Adler Real Estate AG

Start price
Target price
Perf. (%)
€4.56
17.05.22
-
17.05.23
-9.87%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Few uniques
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€146.75
17.05.22
€190.00
17.05.23
-33.90%
18.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management
buy
Twitter Inc.

Start price
Target price
Perf. (%)
€34.73
17.05.22
€45.00
17.05.23
21.96%
23.09.22

Could be worthwhile Investment >10% per year
Known brand
Top 10 in its market
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

buy
Encavis AG

Start price
Target price
Perf. (%)
€18.99
16.05.22
€21.00
16.05.23
7.19%
29.05.22

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€14.20
16.05.22
-
16.05.25
-73.94%
11.03.24

Could be worthwhile Investment >10% per year
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.28
16.05.22
-
16.05.25
29.14%
08.08.22

Could be worthwhile Investment >10% per year
buy
McDonalds Corp.

Start price
Target price
Perf. (%)
€234.95
16.05.22
-
16.05.25
13.30%
11.03.24

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.42
16.05.22
-
16.05.25
-53.44%
11.03.24

Could be worthwhile Investment >10% per year